. . "For instance, cAMP signaling plays a critical role in the late phase of LTP through its main effector PKA [1] and in psychiatric diseases such as schizophrenia, in which the disruption of the interaction between DISC-1 (a scaffold protein) and PDE activity [2] produces altered cAMP activity." . .